These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2903656)

  • 21. Efficacy of celiprolol in hypertension and angina pectoris. Introduction.
    Norris RJ
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1195-6. PubMed ID: 1672600
    [No Abstract]   [Full Text] [Related]  

  • 22. Celiprolol in the treatment of hypertension: a comparison with propranolol.
    Taylor SH; Beattie A; Silke B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S127-31. PubMed ID: 2427842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
    Fogari R; Zoppi A; Tettamanti F; Poletti L; Rizzardi G; Fiocchi G
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Celiprolol--new clinical perspectives beyond cardioselectivity. Proceedings of a symposium. Madrid, Spain, 24 January 1987.
    J Int Med Res; 1988; 16 Suppl 1():1A-80A. PubMed ID: 2906014
    [No Abstract]   [Full Text] [Related]  

  • 26. Celiprolol in systemic hypertension.
    Frishman WH; Flamenbaum W; Schoenberger J; Schwartz GL; Vidt DG; Neri GS; Greenberg S; Lazar E; Godfrey JC; Stevenson A
    Am J Cardiol; 1989 Apr; 63(12):839-42. PubMed ID: 2522723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
    Doshan HD; Rosenthal RR; Brown R; Slutsky A; Applin WJ; Caruso FS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S105-8. PubMed ID: 2427836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical studies of celiprolol in the treatment of arterial hypertension].
    Belovezhdov N; Nachev Ch; Angelova I; Gergova V; Stefanov G
    Vutr Boles; 1985; 24(5):74-7. PubMed ID: 2868573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celiprolol--overview of 6 years of clinical trials experience.
    Pruss TP; Lamon KD; Hagen NS
    J Int Med Res; 1988; 16 Suppl 1():17A-22A. PubMed ID: 2906015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstruction.
    Dorow P; Clauzel AM; Capone P; Mayol R; Mathieu M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S102-4. PubMed ID: 2427835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.
    Milne RJ; Buckley MM
    Drugs; 1991 Jun; 41(6):941-69. PubMed ID: 1715268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of celiprolol and placebo in the treatment of hypertension.
    Capone P; Mayol R
    Br J Clin Pract Suppl; 1985 Jun; 40():65-9. PubMed ID: 2864067
    [No Abstract]   [Full Text] [Related]  

  • 34. INVEST study adds important data for clinical practice in new-onset diabetes.
    Cardiovasc J S Afr; 2004; 15(4):195. PubMed ID: 15322579
    [No Abstract]   [Full Text] [Related]  

  • 35. Celiprolol--review of airways studies.
    Dorow P
    Am J Cardiol; 1988 Feb; 61(5):23C-26C. PubMed ID: 2963522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single-blind randomized comparison of the 24-h antianginal efficacy of celiprolol versus atenolol.
    Jackson NC; Lee PS; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S145-7. PubMed ID: 2427846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchoneutral effects in hypertensive asthmatics--celiprolol versus chlorthalidone.
    Dorow P
    J Int Med Res; 1988; 16 Suppl 1():23A-26A. PubMed ID: 2975609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled study of atenolol in treatment of hypertension.
    Hansson L; Aberg H; Karlberg BE; Westerlund A
    Br Med J; 1975 May; 2(5967):367-70. PubMed ID: 236810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the antihypertensive effects of betaxolol to atenolol.
    Mroczek WJ; Burris JF; Hogan LB; Citron DC; Barker AH; McDonald RH
    Am J Cardiol; 1988 Apr; 61(10):807-11. PubMed ID: 2895577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.